Novocure (Tumor Treating Fields)

Coverage decision: Not covered (Effective: August 1, 2016).

Novocure (Tumor Treating Fields) is not a covered benefit. The decision is based on a Health Technology Clinical Committee (HTCC) coverage determination finalized on March 18, 2016. The HTCC reviewed the evidence on Novocure in January 2016. The committee’s determination, based on a systematic review of the evidence of safety, efficacy and cost-effectiveness, is that Novocure is not a covered benefit. Complete information on this HTCC determination is available here: http://www.hca.wa.gov/about-hca/health-technology-assessment/health-technology-reviews.

In adopting this HTCC coverage determination, the department has concluded that the determination does not conflict with any state statute applicable to L&I. Any coverage for humanitarian or investigational treatment would be considered per WAC 296-20-02850.

Regulatory authority and related information

 

End of main content, page footer follows.

Access Washington official state portal

   © Washington State Dept. of Labor & Industries. Use of this site is subject to the laws of the state of Washington.

Help us improve